Author:
Demirci Selami,Doğan Ayşegül,Başak Neşe,Telci Dilek,Dede Bülent,Orhan Cemal,Tuzcu Mehmet,Şahin Kazm,Şahin Nurhan,Özercan İbrahim Hanifi,Şahin Fikrettin
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference34 articles.
1. Cancer statistics, 2014.;Siegel;CA Cancer J Clin,2014
2. Lee J-m, Juang H-H, Chen M-F, et al.. 19-Nor-2-(3-hydroxypropyl)-1, 25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.;Chiang;Steroids,2011
3. . Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.;Llovet;Hepatology,1999
4. Treatment of hepatocellular carcinoma.;Forner;Crit Rev Oncol Hematol,2006
5. . Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma.;Eguchi;Br J Surg,2011
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献